U.S. federal trademark · Serial No. 76544784
pharmaceuticals, namely, formulations of lysosomal enzymes for replacement of missing lysosomai enzymes due to genetic defects such as glucocerebrosidase deficiency, delivered orally or by intervenous administration, and for human and veterinary usage
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.